Medtronic develops and manufactures a wide range of products and therapies with emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions. Every five seconds, somewhere in the world, a person’s life is saved or improved by a Medtronic product or therapy.

Key Businesses

• Cardiac Rhythm Disease Management manages the full spectrum of cardiac rhythm disorders to improve long-term patient care. The solutions developed at Medtronic allow physicians to monitor and treat their patients' changing cardiac conditions throughout a lifetime. These developments include pacemakers to treat patients with bradycardia (too-slow heartbeat); implantable defibrillators to help patients with tachyarrhythmia (too-fast heartbeat); and diagnostic and monitoring innovations that diagnose heart-related syncope (unexplained fainting), just to name a few.
  
  
• Neuromodulation offers innovative therapies for chronic pain, movement disorders, spasticity, overactive bladder and urinary retention, benign prostatic hyperplasia, and gastroparesis. Medtronic developed and leads the field of neuromodulation, the targeted and regulated delivery of electrical pulses and pharmaceuticals to specific sites in the nervous system.
  
  
• Spinal and Biologics offers products that treat a variety of disorders of the cranium and spine, including traumatically induced conditions, deformities and tumors. Through the introduction of INFUSE® Bone Graft and Minimal Access Spinal Technologies, the business has distinguished itself as a global leader in less-invasive surgical techniques. It also develops a variety of image-guided surgical navigation systems.
  
  
• Diabetes offers insulin pump therapy, continuous glucose monitoring systems, related disposable products and diabetes management software, making Medtronic a world leader in diabetes management.
  
  
• CardioVascular develops products that are used throughout the vascular system and those used for arrested and beating heart bypass surgery. The business markets the industry’s broadest line of heart valve products for replacement and repair, plus auto-transfusion equipment and disposable devices for handling and monitoring blood during major surgery, as well as cardiac ablation devices to treat a variety of heart conditions. The business also offers products and therapies that treat a wide range of vascular diseases and conditions. These products include coronary, peripheral and neurovascular stents, stent graft systems for diseases and conditions throughout the aorta, and distal protection systems.
  
  
• Ear Nose & Throat (ENT) develops and manufactures minimally invasive products and techniques that treat a wide range of ENT conditions. The business markets powered tissue-removal systems and other micro-endoscopy instruments, nerve monitoring systems, disposable fluid control products, image-guided surgery systems and a Ménière's disease therapy device.
  
  
• Physio-Control, a Medtronic company, makes external defibrillator  / monitor / pacemaker products for in-hospital and out-of-hospital use. The wholly-owned subsidiary offers a range of products and services including LIFEPAK® defibrillators used by hospital and emergency services personnel as well as trained responders who have minimal training in CPR and use of an automated external defibrillator. On Dec. 8, 2006, Medtronic announced plans to spin off the Physio-Control business.

Global Presence
Medtronic does business in more than 120 countries. Medtronic World Headquarters is located in Minneapolis, Minnesota. Regional Headquarters include Switzerland and Japan.

Workforce
Medtronic employs more than 37,000 people worldwide.